Evaluating the Efficacy of Therapeutics for Anthrax
$774,845Y01FY2011AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
This IAA provides for the development and standardization of small animal and non-human primate animal models, and may include efficacy testing of therapeutics, including GLP studies to support product licensure. Therapeutics that are efficacious in small animals may be further tested in non-human primate models.
View original record on NIH RePORTER →